Epigenetic Chromosome Interaction Detection for ALS Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing amyotrophic lateral sclerosis (ALS) are inadequate, as they lack precision in predicting disease progression and treatment response, leading to ineffective treatment strategies.
Innovation Solution
A method for diagnosing ALS predisposition by detecting specific epigenetic chromosome interactions using the EpiSwitch platform, which generates ligated nucleic acids from cross-linked chromosome regions, allowing for the identification of predisposition through PCR analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current diagnostic methods are used for ALS, then treatment strategies can be implemented, but the precision in predicting disease progression and treatment response is insufficient
Solution Approach 1:
The patent segments the diagnostic approach by detecting multiple specific chromosome interactions (at least 10 distinct interactions) rather than relying on a single marker. This segmentation of the diagnostic process into multiple interaction detection points enables more precise prediction of disease progression and treatment response, directly addressing the insufficient precision of current methods
Solution Approach 2:
The patent employs excessive action by detecting a comprehensive panel of chromosome interactions beyond what traditional single-marker methods provide. By analyzing at least 10 specific epigenetic chromosome interactions simultaneously, the method over-detects relative to conventional approaches, thereby achieving superior prediction precision and treatment response accuracy
2Measurement precision
If epigenetic chromosome interactions are detected to categorize patients, then early detection and treatment effectiveness improve, but the complexity of the diagnostic method increases
Solution Approach 1:
The patent applies universality by developing a multi-functional diagnostic platform that can detect at least 10 different epigenetic chromosome interactions using a unified approach. The method uses universal PCR-based detection protocols that can simultaneously assess multiple chromosome interactions, thereby maintaining detection precision while reducing the operational complexity compared to performing separate analyses for each interaction
Solution Approach 2:
The patent implements preliminary action by pre-selecting and defining the specific panel of at least 10 chromosome interactions to be detected. This preliminary configuration of the diagnostic panel allows for standardized, routine testing that reduces complexity during actual patient diagnosis, as the target interactions are predetermined and the methodology is established in advance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables early detection of ALS, allowing for more effective treatment by categorizing patients based on epigenetic profiles, potentially improving prognosis and care planning.
Implementation Method 1
which generates ligated nucleic acids from cross-linked chromosome regions
Implementation Method 2
allowing for the identification of predisposition through PCR analysis
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 2A~2B
AI summary
A method of determining the epigenetic chromosome interactions which are relevant to a companion diagnostic.